BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1191 related articles for article (PubMed ID: 2493382)

  • 21. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
    Geppert TD; Lipsky PE
    J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
    Frisch M; Gradehandt G; Mühlradt PF
    Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression.
    Pessara U; Momburg F; Koch N
    Eur J Immunol; 1988 Nov; 18(11):1719-26. PubMed ID: 3144453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
    Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
    Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical and biochemical characterization of purified canine interferon-gamma. Production of a monoclonal antibody, affinity purification, and its effect on mixed lymphocyte culture and mixed lymphocyte kidney culture reactions.
    Fuller L; Fernandez J; Zheng S; Carreno M; Esquenazi V; Yang WC; Miller J
    Transplantation; 1992 Jan; 53(1):195-202. PubMed ID: 1531093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
    Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
    Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J; Moyana T
    Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae.
    Samuel NM; Mirsky R; Grange JM; Jessen KR
    Clin Exp Immunol; 1987 Jun; 68(3):500-9. PubMed ID: 3115648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
    Chang CH; Furue M; Tamaki K
    Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
    Umetsu DT; Katzen D; Jabara HH; Geha RS
    J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
    Ilkovitch D; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
    Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
    Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
    Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
    Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.
    Leszczynski D
    Am J Pathol; 1990 Jan; 136(1):229-37. PubMed ID: 2105059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.